Navigation Links
Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
Date:12/19/2007

WALTHAM, Mass., Dec. 19 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (Amex: ILI) announced today that Alticor Inc., through its subsidiary Pyxis Innovations Inc., has converted a total of $2,039,680 of debt into shares of the Company's common stock. The converted debt represents principal and accrued interest from Promissory Notes issued from October 2002 through January 2003 which were to mature on December 31, 2007. Under the terms of the Promissory Notes, the conversion price of $0.6392 resulted in the Company's issuance of 3,190,987 shares of common stock. Pyxis has previously agreed not to sell these shares prior to August 17, 2008.

"Interleukin Genetics remains at the forefront of delivering consumers genetics-focused personalized healthcare," said James Weaver, Vice President at Alticor. "Today's announcement is further demonstration of our belief in the company's growth opportunities and our continued support as a strategic partner." Mr. Weaver is also Chairman of the Board of Interleukin.

"We appreciate the confidence this transaction shows in Interleukin's business plan and our path forward," stated Thomas Curran, interim Chief Executive Officer of Interleukin Genetics. "This is another important commitment for Interleukin as we continue to leverage our science and capabilities building our twenty year history of leadership in the genetic testing and personalized healthcare sectors."

About Interleukin

Interleukin Genetics, Inc. (Amex: ILI) is a genetics-focused personalized
'/>"/>

SOURCE Interleukin Genetics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Interleukin Genetics Announces Management and Board Appointments
2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
4. Digital Unions RT1(TM) Software Creates Telegenetics Network for Region 3 Genetics Collaborative
5. Response Genetics Reports Second Quarter 2007 Financial Results
6. ZymoGenetics Will Hold Conference Call Today at 5:00 p.m. Eastern Time to Provide Update on rThrombin
7. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
8. deCODE genetics to Webcast Presentation at Thomas Weisel Partners Annual Healthcare Conference
9. ZymoGenetics to Webcast Presentation at Two Upcoming Conferences
10. Response Genetics Announces Presentations/Webcasts at Upcoming Investor Conferences
11. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., INCLINEVILLAGE,Nev.,Nov.23/PRNewswire-FirstCa...ouncedthatNASDAQhasestablishedNovember27,2009asthe...tockholdersresultingfromthesecuritizationtransacti...nDecember15,2009toallstockholdersofrecordonthereco...rshareamountofthedividendat$1.67pershareofcommonst...
(Date:11/23/2009)..., LANSING,Mich.,Nov.23/PRNewswire-FirstCall/--N...ichardT.Crowder,Ph.D.,waselectedtoNeogen,sBoardofD...lders. ,, Crowderhasmorethan40yearsofexperience...lyservesasanadjunctprofessorofagriculturaleconomic...007,heservedasUnitedStateschiefagriculturenegotiat...
(Date:11/23/2009)..., SEATTLE,Nov.23/PRNewswire/--ImmuneDesignC or ...edIDCasExecutiveChairman.Dr.Carterhasasuccessfultr...sthef or merChiefExecutiveOfficeratZymoGenetics,in...,Copenhagen,Denmark. ,, (Photo: http://www.news...tevenReed,IDC,sfounderandChiefExecutiveOfficercomm...
(Date:11/23/2009)..., MOUNTAINVIEW,Calif.,Nov.23/PRNewswire/--Frost...ealthcarecompaniesfordemonstratingleadershipandinn...althcareInnovationAwardsBanquetheldinSanAntonio,Te...rnh/20081117/FSLOGO ) ,, TheHealthcareInnovatio...contributiontothedeliveryandmanagementofhealthcare...
Breaking Biology Technology:PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Richard T. Crowder Joins Neogen's Board of Directors 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 2Excellence in Healthcare Innovation Recognized by Frost & Sullivan 3
...ring of outstanding convertible debentures of Vict...t , , QUEBEC, April 30 /PRNewswire-FirstCall/ - V...d Otto Bock HealthCare GmbH ("Otto Bock") announce...ership agreement to establish a joint venture to d...developed by Victhom,s Neurobionix division. , The...
... April 30 /PRNewswire-Asia-FirstCall/ -- China-Bio... Company"), a leading Chinese firm,specializing in... and,distribution of probiotics products ( http://... Company,s management will present at the upcoming...lations in New York on May 18,2009. , The date...
...RNewswire-FirstCall/ - Oncolytics Biotech Inc. (TS...2009 Annual and Special Meeting of the Shareholder.... (MT) at the Telus World of Science, 701-11 Stree... the meeting, Dr. Brad Thompson, President and CEO...veloping REOLYSIN(R) as a potential cancer therape...
Other Biology Technology:Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 2Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 3Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 4Victhom and Otto Bock sign partnership agreement to establish joint venture for Neurobionix activities 5China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 2China-Biotics, Inc. to Present at CCG Investor Relations' China Rising Conference 3Oncolytics Biotech(R) Inc. Announces Details of 2009 Annual Shareholder Meeting 2
(Date:11/23/2009)... biomedical engineer and cardiologist Tzung "John"...ans distinguish cardiac emergencies requiring imme...h drugs and lifestyle change. , Angiograms, imag...eding the heart, offer an inside view of the inter...n revealing deposits of a dangerous fatty substanc...
(Date:11/23/2009)...edical Sciences (NIGMS), part of the National Inst... for grants in scientific areas it identified as "...ant program to stimulate biomedical research and t...covery and Reinvestment Act (Recovery Act). , "T...significant impact on a field of biomedical scienc...
(Date:11/23/2009)...tor of the Interuniversity Professorship in Law an...niversity of the Basque Country. The Professorship...experts such as researchers in the fields of molec...ics. , The Interuniversity Professorship in Law ...o and the Basque Country was created in 1993. The ...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Research and legislation should go hand in hand, as much as possible 2For Chest Pain in the ER CT Angiography May Be Best 61756 1Artemisinin Resistance Threatens Efforts to Control Malaria 61752 1Artemisinin Resistance Threatens Efforts to Control Malaria 61752 2Artemisinin Resistance Threatens Efforts to Control Malaria 61752 3Artemisinin Resistance Threatens Efforts to Control Malaria 61752 4U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 1U S Government Acts to Ameliorate Guatemala Malnutrition Crisis 61748 2
...nal water sports could all be adversely affected i...coming years prove true, according to research pub...ls . , Scientists from Biotechnology and Biologic...Wyke Research have found for the first time that t...on the amount of phosphorus lost from the soil int...
...Envisat and the Italian Space Agency,s COSMO-SkyMe... Earth during and after the 6.3 earthquake that sh... on 6 April 2009. , Scientists from Italy,s Istit...ente (IREA-CNR) and the Istituto Nazionale di Geof... Aperture Radar (SAR) data from these satellites t...
...director of the Frances and Joseph Weinberg Unit f...ciences at Thomas Jefferson University was recentl...dation grant to identify why drug therapies that s...S) mouse models have proven unsuccessful in human ...eam will closely examine critical aspects of drug ...
Other Biology News:Changing climate will lead to devastating loss of phosphorus from soil 2Satellites show how Earth moved during Italy quake 2Jefferson researcher awarded Landenberger Foundation grant for ALS research 2
...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...ue Arrays are intended for laboratory research use...al buffered formalin and embedded in paraffin. Ti... certified pathologists. Tissue cores were remove...new recipient paraffin block, in an array pattern,...
...n rat tissue extracts (liver, kidney, spleen, and ... was also tested with microsomal fractions prepare...simple and reliable method for measuring NDPase ac...ction of the inorganic phosphate released from NDP...
CNS Side Effect Profile (CNS SEP) from Novascreen-a Caliper Life Sciences Company
Biology Products: